News & Updates | Alliance Healthcare UK

Updates

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Ranitidine 150mg & 300mg Tabs Accord Healthcare

Accord Healthcare are recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity Nnitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
7056195	RANITIDINE TAB 150MG	Accord Healthcare	ALL STOCK
1069087	RANITIDINE TAB 150MG	Accord Healthcare	ALL STOCK
7056203	RANITIDINE TAB 300MG	Accord Healthcare	ALL STOCK
1069046	RANITIDINE TAB 300MG	Accord Healthcare	ALL STOCK
1179191	RANITIDINE TABS 150MG	Accord Healthcare	ALL STOCK

For stock control enquiries please contact Accords Customer Service team on 0800 373573

For medical information enquiries please contact Accords Pharmacovigilance Department on 01271 385257 or medinfo@accord-healthcare.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Paracetamol 500mg (1000s) M&A Pharma

M & A Pharmachem is recalling the above batches as a precautionary measure, because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination. The fungus has been identified as Penicillium citrinum. It is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
7018393	PARACETAMOL TAB BP 500MG	M&A PHARMACHEM	ALL STOCK

For enquiries relating to stock returns please contact Pauline Caddick, Responsible Person: pcaddick@mapharmachem.co.uk

For Medical information enquiries, please contact Cristina Parau, Pharmacovigilance Manager: email cparau@mapharmachem.co.uk

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Drug Alert (Action Within 5 Days) Taxotere Concentrate 80mg per 4ml

Sanofi are recalling the listed batches of Taxotere (Docetaxel) Concentrate due to a production fault potentially leading to an increase in the concentration of Docetaxel in the solution.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3556727	Taxotere (Docetaxel) Concentrate for Solution for Infusion, 80mg per 4ml	Sanofi UK	5F219A

Company contact for all enquiries: Sanofi Medical Information Department on Tel: 0845 3727101 or Email: UK-Medicalinformation@sanofi.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Drug Alert (Action Within 5 Days) Algivon Alg Strl Drsg 10cmsq X 5

Advancis Medical Ltd are recalling the below batch due to the potential packaging integrity.

Please visit the GOV.UK drug alert link: N/A

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3193703	Algivon Alg Strl Drsg 10cmsq X 5	Advancis Medical	WO013976

Action:

1. Contact our sales team (inese.haqure@brightwake.cauk) to request a Return Goods Number (RGN) so that we can reconcile and replace all potentially affected product.

2. Please return the affected product listed above to receive replacement.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Convulex 500mg Capusles

G.L. Pharma GmbH would like to inform Healthcare professionals that they are aware that there is an error on the carton for batches 5E048A and 5H155A in relation to the strength. Inadvertently, the information "Each capsule contains 150 mg valproic acid." was printed on one side of the cartons instead of the correct "Each capsule contains 500 mg valproic acid." All other information, especially the main headings on the package ("Convulex® capsules 500 mg"), however is correct on the carton. G.L. Pharma GmbH confirms that capsules are 500mg strength. The correct strength is also given on the primary blister pack and the patient information leaflet. G.L. Pharma GmbH have informed the MHRA and the MHRA have approved the continued distribution of batches 5E048A and 5H155A until replacement stock is available.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batches
0560656	Convulex 500mg Capusles	Pfizer Ltd	5E048A 5H155A

SUB-TYPE: COMPANY-LED RECALL

Company-Led Dotarem Solution for Injection 15ml

GUERBERT have issued a precautionary recall because a glass particle has been identified in one syringe from this batch..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Healthcare Do Not Stock	Dotarem Solution for Injection 15ml	Guerbert	9263

For further stock enquiries please contact Guerbet Sales Department on 0121 7338542.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Fludarabine 25mg/ml, 1 x 2ml

Sandoz is recalling this batch because particulate matter, believed to be intrinsic to the active pharmaceutical ingredient, was identified in samples.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Fludarabine 25mg/ml, 1 x 2ml	Sandoz Ltd	ER 4824

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

Please contact Sandoz Customer Services for all enquiries relating to the issue on Telephone: 01276 698607

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Genotropin Goquick 5.3mg and Genotropin Goquick 12mg

Pfizer Limited has notified us of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3568979	Genotropin Goquick 12mg	Pfizer Ltd	All unexpired batches
3568961	Genotropin Goquick 5.3mg	Pfizer Ltd	All unexpired batches

This is a caution in use only and therefore we are not accepting stock returns.

Please contact Pfizer's endocrine helpline, tel 0800 521249; email endocrinecare@pfizer.com

Alternatively contact Pfizer Medical Information, tel 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Pioglitazone Accord 30mg Tablets

Accord Healthcare Limited is recalling a specific batch which has inadvertently been distributed in the UK, because it is labelled for the Portuguese market.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Pioglitazone Accord 30mg Tablets	Accord Healthcare Limited	P05615

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

For stock enquiries, please contact Accord Healthcare Limited on 020 8939 3490

For Customer Services enquiries, please contact Accord Healthcare Limited on 020 8901 3507 / 020 8863 1427

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Ambre Solaire

Garnier is recalling the above products of Ambre Solaire to patient level due to a 'Label Misprint'.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batches
3135522	Ambre sol clr prot spry f20 200ml	Garnier	All Batches
3135548	Ambre sol clr prot spry f30 200ml	Garnier	All Batches
3432903	Ambre sol lght&slk milk spf** 200ml	Garnier	All Batches
3432879	Ambre sol lght&slk milk spf30 200ml	Garnier	All Batches
3681285	Ambre sol milk spf30 50ml	Garnier	All Batches
3263555	Ambre solaire kids spray spf 50 200ml	Garnier	All Batches
3135506	Ambre sol clr prot spry** f10 200ml	Garnier	All Batches
3429370	Ambre sol kids rapido sprspf30 150ml	Garnier	All Batches

If you have any questions, then please contact your local Service Centre Customer Services team.